CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-01-16 | SCHABER CHRISTOPHER J Chairman CEO and President | Grant or award | +333,333 | 805,150 | ||
| 2011-12-01 | SCHABER CHRISTOPHER J Chairman CEO and President | Grant or award · Stock Option (Right to Buy) | +2,400,000 | 2,400,000 | ||
| 2011-12-01 | MYRIANTHOPOULOS EVAN Sr VP and CFO | Grant or award · Stock Option (Right to Buy) | +1,200,000 | 1,200,000 | ||
| 2011-12-01 | HORGAN KEVIN Sr VP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +1,200,000 | 1,200,000 | ||
| 2011-12-01 | BREY ROBERT N Sr VP & Chief Science Officer | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2011-12-01 | Warusz Joseph Michael VP of Admin, Controller | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2011-06-22 | THOMPSON VIRGIL Director | Grant or award · Stock Option (Right to Buy) | +191,722 | 191,722 | ||
| 2011-06-22 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +191,722 | 191,722 | ||
| 2011-06-22 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +191,722 | 191,722 | ||
| 2011-06-22 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +191,722 | 191,722 | ||
| 2011-06-22 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2011-06-22 | Brownlie Keith L Director | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2011-05-31 | Warusz Joseph Michael VP of Admin, Controller | Grant or award · Stock Option (Right to Buy) | +800,000 | |||
| 2011-01-31 | HORGAN KEVIN Senior VP; Chief Med Officer | Grant or award · Stock Option (Right to Buy) | +1,250,000 | 1,250,000 | ||
| 2010-09-23 | SCHNITTKER CHRISTOPHER P. VP-Admin., Controller | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2010-09-23 | HAMILTON BRIAN L Chief Medical Officer & Sr VP | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2010-09-23 | BREY ROBERT N Chief Science Officer & Sr VP | Grant or award · Stock Option (Right to Buy) | +850,000 | 850,000 |
Page 14 of 14 · 277 trades